05 February 2019

By Dr Wendy Winnall - PCFA Research Team

The MRI-FIRST study demonstrates the benefit of combined biopsy techniques

MRI has improved the way prostate cancer is diagnosed. Many men now have an MRI scan before their biopsy to detect prostate cancer. MRI can be used to do a targeted biopsy, where the biopsy needles aim for the area where tumours appear on the scan. There has been much debate over whether targeted biopsies can replace the older, systematic biopsy technique. The MRI-FIRST study has compared the two biopsy techniques head-to-head, showing that men would benefit from both types of biopsy for prostate cancer diagnosis.

To read the full article just log into the PCFA Online Community.

If you're not already a member, it is free and easy to join.

Join Online Community Button